Vyera Pharmaceuticals, LLC
- UEI
- DC7GXJ8ECCQ9
- CAGE
- 7GPR6
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- vyera.com
- Founded
- 2015
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| 60P | Washington, DC | 325412 Pharmaceutical Preparation Manufacturing |
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Cipla USA Inc. | Warren, NJ | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| Mirum Pharmaceuticals, Inc. | San Mateo, CA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Vyera Pharmaceuticals, LLC is a company committed to developing and commercializing treatments for serious and neglected diseases with high unmet medical needs. They focus on developing novel treatment options for toxoplasmosis and other rare or serious health conditions.
Through past federal contract awards, Vyera Pharmaceuticals has provided pharmaceuticals and drugs, including the antimalarial and antiparasitic medication Daraprim, used to treat toxoplasmosis and other parasitic infections. These awards have included Delivery Orders from the Department of Veterans Affairs (VA) Veterans Health Administration to supply Daraprim tablets, with no set-asides utilized. Additionally, Vyera Pharmaceuticals has partnered as a prime contractor on a Blanket Purchase Agreement (BPA) awarded by the VA National Acquisition Center to procure Daraprim, valued at $2.5 million over a one-year ordering period ending October 2022.
Vyera Pharmaceuticals currently holds several federal contract Indefinite Delivery Vehicles (IDVs) to provide pharmaceuticals and related products to the VA. These include a $3.5 million Federal Supply Schedule contract for drugs, pharmaceuticals and hematology products, valid through September 2027. Vyera also holds a $450,000 BPA awarded October 2022 by the National Acquisition Center to supply Daraprim under the VA's Pharmaceuticals and Drugs schedule. This single-award BPA aims to ensure reliable access to this medication for VA pharmacies and facilities through October 2024. Overall, these IDVs enable streamlined ordering of essential pharmaceuticals, while leveraging competitive pricing, to serve the clinical needs of veterans under VA care.
Quick answers
Is Vyera Pharmaceuticals, LLC registered in SAM.gov?
Vyera Pharmaceuticals, LLC's SAM.gov registration expired on October 23, 2022.
Which contract vehicles does Vyera Pharmaceuticals, LLC hold?
Vyera Pharmaceuticals, LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Vyera Pharmaceuticals, LLC's most recent federal award?
Vyera Pharmaceuticals, LLC's most recent federal contract award is Daraprim (pyrimethamine) tablets 25 MG - size 100 (36C26119F0347), from Veterans Integrated Service Network 21 (VHA), on April 9, 2019.
On GovTribe
See Vyera Pharmaceuticals, LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors